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To identify molecules that regulate Schwann cell migration, 
we have generated a panel of monoclonal antibodies against 
Schwann cell surface antigens that modulate Schwann cell 
migration in /n vitro bioassays. One of these antibodies, 
SMRA 1, recognizes a 26 kDa Schwann cell surface mem-
brane protein identified here as CD9. SMRA 1 enhances 
Schwann cell migration on two biologically relevant sub-
strates: living axons of cultured dorsal root ganglion neu-
rons, and cryostat sections of sciatic nerve. This CD9-in-
duced regulation of Schwann cell motility is correlated with 
a rise in cytosolic calcium and enhanced tyrosine phos-
phorylation of several Schwann cell proteins. These results, 
together with the findings of Hadjiargyrou and Patterson 
(1994), implicate CD9 as an important regulator of Schwann 
cell behavior in peripheral nerve. 
[Key words: Schwann cells, CD9, migration, calcium, ty-
rosine phosphorylation, antibodies J 
Schwann cells migrate extensively during the development and 
regeneration of peripheral nerves. To populate the PNS during 
development, Schwann cells first migrate along axons at the 
outer surface of the developing nerve and then migrate perpen-
dicular to the nerve axis into the axon bundles (Peters and Muir, 
1959; Cravioto, 1965; Billings-Gagliardi et al., 1974; Ziskind-
Conhaim, 1988). Migrating Schwann cells may also play a role 
in axon growth and guidance during development (Keynes, 1987; 
Noakes and Bennett, 1987; Noakes et al., 1988). Schwann cell 
migration is also a crucial and often limiting factor in recovery 
from PNS injuries and neuropathies (Williams et al., 1983; Hall, 
1986a,b; Griffin et al., 1987; Fields et al., 1989; Fenely et al., 
1991; Guernard et al., 1992; Franklin and Blakemore, 1993). · 
Schwann cell migration in vivo can occur on two substrates: 
axonal surfaces and extracellular matrix components. Thus, there 
are a number of candidate molecules that might regulate Schwann 
cell migration. During development and regeneration, migrating 
Schwann cells express elevated levels of adhesion molecules 
(Nicke and Schachner, 1985; Daniloff et al., 1986; Daston and 
Ratner, 1991 ), extracellular matrix molecules and their recep-
tors (Engvall et al., 1990; Sanes et al., 1990; Lefcort et al., 1992; 
Sirronen et al., 1992; Jaakola et al., 1993), trophic factors and 
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their receptors (Heumann et al., 1987; Taniuchi et al., 1987; 
K.anje et al., 1989; Acheson et al., 1991; Toma et al., 1992); 
proteases (Meier et al., 1989; Kiousssi et al., 1992), and the 
growth and motility regulating protein GAP-43 (Curtis et al., 
1992). Of these molecules, NGF, p75 NGF receptor, merosin, 
laminin, fibronectin, and N-cadherin have been shown to reg-
ulate Schwann cell migration (Baron-Van Evercooren et al., 
1982; McCarthy et al., 1 983; Longo et al., 1984; Le Beau et al., 
1988; Letourneau et al., 1991; Bailey et al., 1993; Anton et al., 
l 994a,b). Thus, the temporal correlation between migration and 
elevated Schwann cell expression of various cell surface and 
extracellular matrix molecules is a useful indicator of which 
molecules may modulate Schwann cell migration. This indicator 
will, however, neither identify novel functional molecules nor 
implicate other known molecules not yet found in Schwann cells. 
To identify such functionally relevant molecules, we generated 
a panel of monoclonal antibodies (mAb) that modulate Schwann 
cell migration in two in vitro bioassays. These mAbs are referred 
to by the prefix SMRA, for Schwann cell migration regulating 
antibodies. 
To generate mAbs against antigens that specifically modulate 
Schwann cell migration, mice were first tolerized to a homog-
enate of fibroblasts using the immunosuppressant drug cyclo-
phosphamide (Matthew and Sandrock, 1987), and then im-
munized with a Schwann cell homogenate. One of the mAb, 
SMRAl, from this fusion dramatically facilitates Schwann cell 
migration in vitro. SMRAl was found to recognize a 26 kDa 
Schwann cell surface glycoprotein known as CD9. 
In the nervous system, CD9 is found on embryonic sensory, 
sympathetic, and motor neurons, adrenal chromaffin cells, PNS 
and CNS glial cells, retina, and on certain retinoblastoma and 
neuroblastoma cell lines (Boucheix and Benoit, 1988; Martin~ 
Alonso et al., 1992; Tole and Patterson, 1993). It is present on 
rat Schwann cells as early as embryonic day 17. Recent studies 
on molecules that define positional information in the PNS have 
identified a putative epitope on CD9 that is expressed prefer-
entially by Schwann cells in rostral rather than caudal nerves 
and ganglia (Suzue et al., 1990; Kaprielian and Patterson, 1993). 
CD9 is also a major cell surface protein in various hematopoetic 
cells, including pre-B cells, platelets, and activated T lympho-
cytes (Jennings et al., 1990; Masellis-Smith et al., 1990). In pre-B 
cells and platelets, CD9 regulates cell activation and aggregation, 
possibly through an association with an integrin (Slupsky et al., 
1989). In the process, mAbs to CD9 induce tyrosine phos-
phorylation and increases in intracellular calcium concentration 
in platelets (Boucheix et al., 1987; Favier et al., 1990; Seehafer 
and Shaw, 1991; Kroll et al., 1992; Yatomi et al., 1993). mAbs 
to CD9 also enhance neutrophil adhesion to endothelial cells 
(Forsyth, 1991). Furthermore, CD9 regulates cell motility in a 
variety of cell lines (Ikeyama et al., 1993). CD9 could therefore 
regulate cell adhesion and cell motility in Schwann cells. 
We report here that a mAb against CD9, SMRAl, stimulates 
Schwann cell migration on cryostat nerve sections and on living 
axons. SMRA l also induces an increase in intracellular calcium 
levels and in the tyrosine phosphorylation of several Schwann 
cell proteins. Such functional effects of CD9, as well as the 
differential expression of a putative CD9 epitope on Schwann 
cells, suggest that CD9 is an important regulator of Schwann 
cell behavior in the PNS. 
Materials and Methods 
Monoclonal antibodies to CD9 
Antibody SMRA I is one of the panel of mAbs raised against Schwann 
cell antigens using the previously described cyclophosphamide immu-
nosuppression paradigm (Matthew and Sandrock, 1987). A BALB/c 
mouse was tolerized with an injection of 15 mg of protein from whole 
cell extracts of the rat 3T3 fibroblast cell line. Over the next 48 hr, three 
injections of cyclophosphamide were administered at 100 mg/kg dosage 
at 14 hr intervals. The animal was tolerized with the same antigens and 
cyclophosphamide again at 14, 42, and 70 d. Two weeks after the second 
tolerization procedure (day 28), the animal was immunized with 20 mg 
of protein from whole cell extracts of the mouse Bl.I Schwann cell line. 
The Bl.I cell line was generated by immortalizing primary mouse 
Schwann cells from neonatal sciatic nerve with a transforming retrovirus 
(B. Yankner and W. D. Matthew, unpublished observations). Theim-
munization procedure was repeated again at 56 and 84 d. Three days 
after the final immunization (day 87), the mouse was sacrificed and 
hybridomas were made from its spleen as described by Matthew and 
Sandrock (1987). Hybridomas grown in RPMl/10% fetal calf serum 
media were subcloned repeatedly. SMRAl is a mAb of the IgM isotype. 
mAbs ROCA!, ROCA2, and B2CI I have been previously described 
as specific to rat CD9 (Akeson and Warren, 1984; Kaprielian and Pat-
terson, 1993; Kaprielian et al., 1994) and are of the lgG isotype. 
Immunoprecipitation, electrophoresis, and immunoblotting 
Triton X-100-soluble fractions of adult rat sciatic nerve membranes or 
S-16 Schwann cell membranes (Goda et al., 1991) were prepared and 
CD9 was immunoprecipitated from these extracts, using a protein G-
sepharose column and the SMRAl mAb, as described by Kaprielian 
and Patterson (1993). An anti-mouse lgM mAb of the lgG isotype 
(Boehringer-Mannheim) was used to bind the SMRAl-CD9 complex 
to the protein G-sepharose column. Pure CD9 is a gift from Dr. Z. 
Kaprielian. Platelet extracts were prepared as described by Boucheix et 
al. (1983). 
One-dimensional SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed according to the method ofLaemmli (1970) on 
10% polyacrylamide gels. All samples were run under nonreducing con-
ditions. Following transfer to nitrocellulose (0.45 µm, Bio-Rad), protein 
bands were detected by immunoblotting. The transfer was performed 
overnight using a Bio-Rad minigel transfer apparatus; the blots were 
then blocked for 30 min in Tris-buffered saline (TBS; 0.9% NaCl, 20 
mM Tris-HCI, pH 7.4) containing 5% nonfat dry milk (Carnation) at 
room temperature. The blocked nitrocellulose was incubated for 3 hr 
at room temperature with hybridoma supematants from one of the 
following mAbs: ROCA!, ROCA2, B2Cl I, and SMRAI. After three 
15 min washes in TBS/0.5% Tween-20 (TBST), blots were incubated 
for I hr with 1:100 biotinylated goat anti-mouse lgG or lgM (Vector) 
in blocking solution. Blots were then washed three times in TBST and 
incubated for 45 min with avidin-biotinylated horseradish peroxidase 
solution (ABC kit, Vector). After the final incubation, blots were washed 
twice in TBST and once in TBS prior to detection of bound antibodies 
with 0.05% diaminobenzidine (DAB) in 0.03% hydrogen peroxide. The 
reaction was stopped after 15 min by transferring the blots to distilled 
water. 
I mmunohistochemistry 
Primary Schwann cells from one day rat sciatic nerve were dissociated 
and cultured in RPMI/ I 0% FCS medium as described by Brockes et al. 
( 1979). After 2 d in culture, cells were incubated live in hybridoma 
supernatant for 1 hr at room temperature. After three 5 min rinses in 
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RPMl/10% FCS at room temperature, the cells were incubated in flu-
orescein-conjugated goat antiserum to mouse immunoglobulins (I :50 
dilution in RPMl/10% rat serum; Antibodies Inc.) for 45 min at room 
temperature. Following three 5 min rinses in RPMl/10% FCS at room 
temperature, cells were mounted in the same medium for observation 
in a Zeiss epifluorescence microscope. 
In some experiments, fresh-frozen 15 µm cryostat sections of normal 
or denervated sciatic nerves collected on gelatin-coated slides were stained 
with SMRAI. 
Bioassays for Schwann cell migration 
In vitro bioassay to study Schwann cell migration on cryostat tissue 
sections. Thoracic level, dorsal root ganglia (DRG) were removed from 
1 d Sprague-Dawley (Charles River) rat pups and placed in ice-cold 
RPMI medium (GIBCO) supplemented with 10% fetal calf serum (FCS, 
Hyclone). After dissecting away blood vessels and nerve rootlets, ganglia 
were treated with 0.03% collagenase (Sigma) and 0.25% trypsin (Sigma) 
in RPMI medium for 30 min at 37°C. Subsequently, DRGs were in-
cubated with 0.01% DNase (Sigma) and 0.25% anti-trypsin (Sigma) in 
RPMI/ I 0% FCS medium for 15 min at 3 7°C. After two rinses in RPMI/ 
10% FCS medium, DRGs were explanted onto 22 µm longitudinal 
cryostat sections of normal or denervated sciatic nerves (the latter are 
distal stumps of sciatic nerves transected in vivo 7 d prior to use). 
Explants were cultured for 72 hr in a 50:50 mixture ofRPMl/10% FCS 
medium and hybridoma supernatant. Schwann cells migrating out of 
the DRG explant onto nerve substrates were then visualized by incu-
bating the cultures with JO mM 5,6-carboxyfiuorescein diacetate suc-
cinimidyl ester (Molecular Probes Inc.) in TBS for 5 min at room tem-
perature. Cultures were immediately examined in a Zeiss microscope 
equipped with an epifiuorescence filter. Images of these cultures were 
collected onto an optical disk drive and the extent of Schwann cell 
migration was measured using the IMAGE 1 program (Universal Imaging 
Inc.). A rectangular grid divided into several 100 µm2 squares was pasted 
on to each of these images, and the shortest distance between the edges 
of the DRG and the leading Schwann cells was measured. An average 
of these measurements indicates the mean maximum distance Schwann 
cells have migrated on a particular substrate from a particular DRG 
explant. Measurements from different experimental groups were statis-
tically analyzed for differences using Student's t test (confidence interval 
= 95% or higher). 
In a number of experiments, pieces of sciatic nerve from neonatal 
day 1 rats, instead ofDRGs, provided the source of migrating Schwann 
cells. Sciatic nerves were removed from rat pups, cut into -1 mm pieces 
using a micro dissecting scissors, and cultured for 48 hr on tissue culture 
plastic in RPMl/10% FCS medium to facilitate the emigration of most 
of the fibroblasts from the nerve explants (Morrisey et al., 1991). Fol-
lowing this initial incubation, nerve explants were harvested and ex-
planted onto appropriate nerve substrates as described above. 
After carboxyfluorescein imaging, some coverslips were washed sev-
eral times in PBS and stained with antibodies to SlOO (a Schwann cell-
specific marker, Dako Corp.) or neurofilament (Sigma). Cultures were 
also counterstained with 10 µM bisbenzamide (Sigma) to stain nuclei. 
In vitro bioassay to study Schwann cell migration on axonal surfaces. 
Sciatic nerves of adult, Sprague-Dawley rats were crushed in vivo two 
days prior to the removal of corresponding DRGs at levels L4, LS, and 
L6. Following removal, DRGs were incubated at 37°C in RPMl/N2 
media (RPM! + 0.5 mg/ml insulin, IO mg/ml transferin, 0.63 µg/ml 
progesterone, 1.611 mg/ml putrescene, and 0.52 mg/ml sodium selenite) 
containing 0.25% collagenase type II (Sigma) for 1.5 hr. At the end of 
this incubation, DR Gs were triturated ( 16 passages) with a fire-polished 
glass pipette and 0.025% trypsin was added to the cell suspension. After 
15 min at room temperature, 80 µg/ml DNase, and 100 µg/ml soybean 
trypsin inhibitor were added to the suspension. Following one round of 
gentle trituration to break up the DRGs into small neuron-Schwann 
cell clumps, cells were suspended in 15 ml of RPMI/ I 0% FCS media 
and centrifuged for 10 min at 500 x g. The cell pellet was resuspended 
in RPMI/10% FCS and plated on laminin (10 µg/ml)-coated 35 mm 
petri dishes (Falcon) at a density of500 cells/dish. After 24 hr in culture, 
cells were placed onto a 37°C stage on a Hoffman modulation contrast 
optics microscope, and time-lapse recordings ofSchwann cells migrating 
on neurites were made using video microscopy. After monitoring the 
baseline activity for 30 min, media with mAbs (5 µg/ml) were perfused 
into the culture and the effects of mAbs on Schwann cell migration rates, 
as well as the morphology of migrating Schwann cells and neurites, were 
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Figure 1. SMRAI mAb recognizes CD9. Triton X-100-soluble frac-
tions of membranes from adult sciatic nerve (a-c), S-16 Schwann cells 
(d-f), platelets (g, h), and immunoaffinity purified CD9 (i,j) were blotted 
with SMRAI (a, d, g, i), ROCA! (b, e, h), ROCA2 (c), B2Cl 1 (f, j). 
All of these antibodies recognize the same 26 kDa CD9 protein. ROCA2 
and B2Cl 1 also recognizes a 28 kDa band that is a glycosylated form 
ofCD9 molecule. SMRA I does not recognize any proteins in the Triton 
X-100-insoluble membrane/cytoskeletal fraction of the adult sciatic 
nerve (con., k). Approximately 100 µg of protein was loaded in each 
lane. 
monitored for I hr. At the end of the time-lapse recordings, cultures 
were fixed and stained with S 100 antibody (a Schwann cell marker) to 
verify that the monitored cells were Schwann cells. 
In some of the experiments, mAbs were added to the cultures at 24 
hr and cultures maintained for another 24 hr before staining with 5,6-
carboxyfluorescein diacetate succinimidyl ester and bisbenzamide. Im-
ages of such cultures were used to analyze the extent of neuron-Schwann 
cell association with and without mAbs. Carboxyfluorescein labels all 
living cells and their processes. Bisbenzamide, used to stain the cell 
nuclei, avoids the identification of the large neuritic varicosities as mi-
grating cells. 
Tyrosine phosphorylation assay. Dissociated Schwann cells, prepared 
from neonatal rat sciatic nerve as described above, were cultured at a 
density of 50,000 cells/well for 48 hr in 24 well culture dishes. The cells 
in each well were then incubated for 45 min with approximately 2 µg 
of SMRA 1 or SMRA5 (control mAb). Some of the wells were left un-
treated in RPMI/ 10% FCS medium. The cells were then rinsed twice 
in RPMI medium and harvested in I 00 µl of boiling SDS-PAGE sample 
buffer (20% glycerol, 4% SDS, 0.125 M Tris, 0.0 I mg/ml bromophenol 
blue, 10% 2-mercaptoethanol, pH 6.8) containing 0.5 mM vanadate. 
Twenty-five microliter samples were then loaded into each well of a 
10% polyacrylamide, Bio-Rad minigel and run at 200 mV. Separated 
proteins were blotted onto nitrocellulose, blocked first with 4% calf 
serum containing 0.5 mM vanadate and then with 10% calf serum in 
TBS (pH 7.4) overnight at 4"C. Bands of protein containing phosphor-
ylated tyrosine were identified using an anti-phosphotyrosine mAb 
(P3300; Sigma) or a rabbit polyclonal antiserum (AB 1600, Chemicon) 
diluted I :750 in 10% calf serum. As stated by the manufacturers, these 
antibodies react specifically with phosphotyrosine-containing mole-
cules. Positive bands were visualized with an anti-mouse Vectastain 
ABC-HRP kit using diaminobenzidine (DAB) as a substrate for per-
oxidase. In some experiments, labeled protein bands were visualized 
with an enhanced chemiluminescence (ECL, Amersham) kit using lu-
minol as the substrate for peroxidase. 
Calcium imaging. Fluo-3 AM, a membrane-permeant calcium in-
dicator that increases in fluorescence with increasing calcium concen-
trations, was used to monitor calcium changes induced in Schwann cells 
by SMRA I. Primary cultures of Schwann cells in a 35 mm petri dish 
were incubated wi th 2 ml of Opti-MEM medium (GIBCO) containing 
10 µM Fluo-3 acetoxymethyl ester (AM) (Molecular Probes Inc.) and 
the nonionic detergent pluronic acid Fl 27 at 0.5 mg/ml. Heavy metals 
that might bind to Fluo-3 and interfere with its calcium sensitivity were 
chelated by adding 10 M Tetrakis (2-pyridyl methyl) ethylenediamine 
(TPEN) to the incubation medium. After an hour of incubation at 37"C, 
Fluo-3-loaded cells were washed twice in Opti-MEM and placed onto 
a 37°C stage on a Zeiss microscope. Images ofFluo-3-labeled cells were 
collected every 1.25 min using the IMAGE 1 system, an SIT camera, a 
computer-controlled shutter on the UV light source, and an optical 
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Figure 2. SMRA I and ROCA I bind the same 26 kDa protein. Proteins 
were immunoprecipitated from Triton X-100-soluble adult sciatic nerve 
fractions with SMRAI and Western blotted with ROCA! or SMRAI. 
ROCA I recognized a 26 kDa protein band in the SMRA 1 immuno-
precipitate (left lane). The same protein band was also recognized by 
SMRA 1 (right lane). 
image recorder. After 10-15 min of baseline recording, medium with 
mAbs (5 µg/ml) was perfused onto the culture and the fluorescence 
changes induced in cell so mas (and processes, when possible) were mon-
itored. Fluorescence changes induced by mAbs in the cell body area 
was calculated as M IF [(fluorescence with antibody - fluorescence 
baseline)/ fluorescence baseline]. 
Results 
Generation of mAbs to Schwann cell swface antigens 
Antibodies to Schwann cell antigens were generated using the 
cyclophosphamide immunosuppression paradigm described 
previously (Matthew and Sandrock, I 987). Cyclophosphamide 
was used to suppress the immune response of m ice to a 3T 3 
fibroblast homogenate; subsequently, animals were immunized 
with a BI . I Schwann cell homogenate. Our goal was to generate 
mAbs to Schwann cell surface antigens that are involved in cell 
migration. Since fibroblasts are known to migrate in peripheral 
nerve and are known to use ubiquitous molecules such as fi-
bronectin for their migration, we hypothesized that tolerization 
with fibroblast antigens followed by immunization with Schwann 
cell antigens would bias the immune response in the desired 
direction, in this case, functionally relevant and possibly novel 
Schwann cell specific antigens. Antibodies were first screened 
immunohistochemically for their ability to recognize Schwann 
cell surface membranes on primary, rat Schwann cells and sciatic 
nerve sections. Positive mAbs were then screened for their ef-
fects on in vitro Schwann cell m igration bioassays. One of the 
mAbs resulting from this fusion , SMRA 1, was found to label 
Schwann cell membranes strongly and to enhance the rate of 
Schwann cell migration in in vitro bioassays, thus implicating 
the SMRA I antigen as an important regulator of Schwann cell 
migration. 
Characterization of the SMRAJ antigen as CD9 
Triton X- 100-soluble fractions of membrane fractions from 
BI. I o r S- I 6 Schwann cell lines and adult sciatic nerve ho-
mogenates yielded st rong SMRA 1 binding signals in dot blots, 
whereas no signal was detectable in the detergent insoluble frac-
tions, suggesting that the SMRA I antigen is likely to be an 
integral membrane protein rather than a cytoskeletal o r extra-
cellular matrix m olecule. The SMRAI antibody also bound 
strongly to purified CD9 in dot blots (data not shown). In an 
effort to identify the SMRAI antigen unambiguously, detergent-
soluble membrane fractions from adult sciatic nerves or S-1 6 
Schwann cells were immunoblotted with SMRAI mAb (Fig. 
1 a,d). SMRA l labels a 26 k.Da band, identical in molecular 
weight to CD9. The same 26 kD a band is also labeled by three 
previously characterized CD9 mAbs, ROCA 1 (Fig. Ib,e), ROCA2 
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Figure 3. lmmunobistochemical labeling ofSMRAl in primary rat Scbwann cells and adult sciatic nerve sections. Living Schwann cells or cryostat 
sections of sciatic nerve were labeled with SMRA I as described in Materials and Methods. SMRA I labeled membranes in the cell soma and leading 
edges (arrowheads) of the bipolar processes (a, b). In nerve section, the outer Scbwann cell membrane (arrowhead, c) and axoplasm (a"ow, c) were 
stained. Scale bars: a and b, 20 µm; c, 15 µm. 
(Fig. le), and B2CI I (Fig. If). In membrane extracts of platelets, 
a rich source ofCD9, ROCA! and SMRAl recognize the iden-
tical 26 kDa band (Fig. lg,h). SMRAl and B2Cl 1 also recognize 
the identical 26 kDa band in immunoblots of pure CD9 (Fig. 
l ij). As in dot blots, SM RA I does not bind any protein bands 
in the immunoblots of Triton X-100-insoluble fractions from 
adult sciatic nerve (con., Fig. I k). 
In addition, when the SMRAl antigen was immunoprecipi-
tated with the SMRA I mAb and immunoblotted with the 
ROCAI mAb, the 26 kDa protein ispositivelystained byROCAl 
(Fig. 2). Thus, both ROCA! and SMRAl recognize the same 
26 kDa CD9 protein. Neither the antibodies to Schwann cell 
surface integrins nor anti-mouse immunoglobu)jns immuno-
precipitated CD9. 
I mmunohistochemical localization of the SMRA 1 antigen 
In living, primary rat Schwann cells, surface membrane staining 
is observed with SMRA I mAb. Prominent labeling is observed 
on the cell soma region (Fig. 3a). The leading edges of the 
Schwann cell bipolar processes also label (arrowheads, Fig. 3a). 
When a freshly harvested cell pellet of S-16 Schwann cells was 
frozen , sectioned, and stained with SMRAI , labeling is seen 
only on the cell surface, not in the cytoplasm (data not shown). 
In fresh frozen, adult rat sciatic nerve sections, SMRA I labels 
both the outer Schwann cell membranes (Fig. 3c, arrowhead), 
and the axoplasm (Fig. 3c. arrow). Occasionally, abaxonal 
Schwann cell surface membrane or axonal surface membrane 
staining is observed. No specific staining is observed in the 
Schwann cell cytoplasm or in the myelin layers. We were unable 
to determine if endoneurial fibroblasts labeled with SMRAl in 
nerve sections. Treatment with secondary antibodies alone did 
not label primary Schwann cells or nerve sections. 
The SMRAJ antibody promotes Schwann cell migration 011 
sciatic nerve sections 
Sections of frozen sciatic nerve provide an in vitro substrate 
related to what Schwann cells encounter during their migration 
in vivo. In order to determine if Schwann cells use cell surface 
CD9 for their migration, we studied the effect of two anti-CD9 
mAbs on Schwann cell migration on nerve substrates. Briefly, 
DRGs from neonatal day 1 rats were explanted onto normal 
adult sciatic nerve sections and cultured in RPMI/10% FCS 
containing mAbs for 72 hr. Migrating Schwann cells were then 
visualized with a vital dye, carboxy fluorescein. We have pre-
viously demonstrated that the primary biological event in this 
bioassay is Schwann cell migration, not neurite extension or 
fibroblast migration (Anton et al., l 994a). Nearly aJI of the 
migrating cells in this assay (>95%) are Schwann cells, and 
neurite outgrowth is limited to 10-50 µm around the DRG 
ex.plant. In the presence ofSMRAl antibody, the average max-
imum distance of Schwann cell migration is 918 ± 42 µm (n = 
12), whereas the migration in the absence of mAbs is 371 ± 17 
µm (n = I 0) or in the presence of a control mAb, SMRA5, is 
366 ± 30 µm (n = 6) (Fig. 4a-c). SMRA5 recognizes a Schwann 
cell surface antigen that remains to be identified. In addition to 
the SMRA5 control, a number of other mAbs that bind Schwann 
cell surfaces a lso do not affect migration (data not shown). An-
other anti-CD9 mAb, B2C 11 , also enhances migration to the 
extent of 848 ± 109 µm (n = JO) (Fig. 4d). 
Since CD9 is expressed on PNS neurons as well as Schwann 
cells (Tole and Patterson, 1993), the effect of the SMRA 1 on 
glial migration from the DRG ex plant could be due to an indirect 
effect, via the neurons. This, however, is unlikely because SMRA 1 
also promotes Schwann cell migration from sciatic nerve ex-
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Figure 4. SMRAJ and B2Cl 1 enhanced Schwann cell migration over 
adult sciatic nerve substrates. Schwann cells that migrate out of a DRG 
explant onto nerve substrates in the presence of RPMl/ 10% FCS (a), 
SMRA5 mAb (b), SMRAI mAb (c), and B2CI I mAb (d) were visu-
alized with carboxyftuorescein after 72 hr in culture. Scale bar, 150 µm. 
plants, which contain Schwann cells but no neurons [SMRAl, 
875 ± 42 .um (n = 9); no mAb, 411 ± 41 .um (n = 7)). Moreover, 
pretreating the nerve substrate with SMRA l and not including 
the mAb in the culture medium does not result in enhanced 
migration. Thus, it is likely that direct binding of anti-CD9 
Figure 5. SMRA 1 enhanced Schwann cell motility and adhesion on 
living neurites. Schwann cells (arrows) in contact with living axons were 
monitored prior to (a) and after (b-d) antibody perfusion. Schwann cells 
were barely motile prior to the addition of antibodies. After exposure 
to antibodies, Schwann cells adhere to and migrate on axons more 
rapidly. Arrowhead points to the neuron--Schwann cell clump from which 
the Schwann cells migrated out. Time (minutes) after antibody stimu-
lation is noted in each panel. Scale bar, 35 µm. 
mAbs to the migrating Schwann cell surface is essential for 
increased migration. The effect of SM RA 1 on migration is more 
prominent on a normal adult sciatic nerve substrate than on a 
denervated sciatic nerve substrate. For example, on a normal 
nerve substrate, a 150% enhancement was seen in the presence 
ofSMRAl (when compared to the control mAb), whereas only 
a 79% enhancement was seen when denervated substrate is used 
instead. 
The SMRAJ antibody promotes Schwann cell migration on 
living axons 
The bioassay using nerve substrates mimics Schwann cell mi-
gration on extracellular matrix and basement membrane com-
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Figure 6. Increased number of Schwann cells adhere to living neurites in the presence of SMRA I. Number of Schwann cells (arrows) associated 
with Jiving neurites were counted in the presence ofSMRAI mAb (a), SMRA5 (b), and RPMl/10% FCS (c). Both axons and Schwann cells were 
labeled with carboxyfluorescein. Bis benzamide nuclei counterstain (arrowhead, d) and the bipolar, morphology of the cell in contact with the 
neurite (arrow. c) indicate that it is a Schwann cell not a fibroblast or large neuritic varicosity. dis the bis benzamide nuclear counterstain of c. 
Carboxyftuorescein labeled fibroblasts are identified by their flattened, round cell morphology and by the extensive membrane veil they display at 
their perimeter. Scale bar, 50 µm. 
ponents. Schwann cells also migrate on axons, however. There-
fore, we tested the ability of SMRA 1 to influence Schwann cell 
migration on living axons. Precrushed, adult DRGs were dis-
sociated into small neuron-Schwann cell clumps (-100 µm in 
diameter) and cultured in RPMl/10% FCS medium. Observa-
tion of cultures at various time points indicated that neurons 
in the clumps establish extensive neurite networks by l 0-16 hr 
in culture. Schwann cells in the neuron-Schwann cell clumps 
subsequently migrate along these neurites. Schwann cells are 
easily identified initially, because of their bipolar morphology 
and later, by SlOO expression. After Schwann cells begin to 
migrate on neurites (approximately 24 hr), baseline Schwann 
cell morphology, migration rates, and attachment to neurites 
were monitored by video microscopy for 45 min prior to adding 
antibody to cultures. Exposure to SMRAl enhances Schwann 
cell attachment to the neurites and increases their migration 
rates. Two typical Schwann cells are shown in Figure 5a (arrows) 
in their basal state. The one on the left (Schwann cell 1) is 
attached to neurites on its bipolar ends whereas the one on the 
right (Schwann cell 2) randomly migrates on the axons at a rate 
of -8 µmlhr. Beginning from about 15 min after SMRA 1 per-
fusion, Schwann cell l moves downwards and eventually at-
taches strongly to the neurites (Fig. 5b-d). During and after this 
period ofincreased attachment, enhanced lamellapodial activity 
is seen in this Schwann cell. The migration rate ofSchwann cell 
b increased to - 30 µm/hr after mAb exposure as it moved back 
and forth along the main neurite and one of its small branches 
(Fig. 5b--d). No such changes in morphology or migration rates 
are observed after perfusion of culture medium devoid of mAbs 
or containing control mAbs that bind to other antigens on 
Schwann cell surface. Efforts to reverse the effects of SMRAl 
mAb by washing with mAb-free medium did not yield any 
changes in I hr after removal of mAbs. 
In an effort to investigate if anti-CD9 mAbs cause enhanced 
affinity of Schwann cells to neurites, we added SMRA l mAb 
to cultures at 24 hr and evaluated the number ofSchwann cells 
attached to neurites. An average of 4.3 ± 0.34 (n = 34) Schwann 
cells associate with neurites in the presence of SMRAl, com-
pared to 2.43 ± 0.26 (n = 30) in the presence of control mAb 
SMRA5, or 2.31 ± 0.24 (n = 38) in RPMl/10% FCS medium 
(Fig. 6). It is likely that under control conditions most of the 
Schwann cells remained within the neuron-Schwann cell clump, 
instead of migrating out along the neurites. 
It is apparent from these in vitro bioassays that the anti-CD9 
mAbs bind to the CD9 molecule on the Schwann cell surface 
and influence its rate of migration and adhesion. To begin an 
investigation of second messenger pathways that may mediate 
these effects, we studied the effect of SMRA 1 mAb on tyrosine 
phosphorylation and intracellular calcium. 
The SMRAJ mAb elicits a rise in internal calcium levels in 
Schwann cells 
Intracellular calcium levels before and after exposure to mAbs 
were monitored using a fluorescent calcium indicator, Auo 
3-AM. Images of Auo 3-AM-loaded cells were recorded at one 
minute intervals using an SIT camera. After 15 min of baseline 
measurement, mAbs were perfused into the culture and changes 
in calcium levels recorded. Exposure to SMRA 1 leads to a 63 
± 9% increase in Auo 3-AM fluorescence, indicating a rise in 
internal calcium levels. This rise begins 12- 15 min after the 
mAbs are pulsed in, and reaches its peak at about 35 min. 
Elevated calcium levels remain stable for 2-3 min, before re-
turning to baseline levels by 50 min after stimulation (Fig. 7). 
In a majority of the experiments, F1uo 3-AM primarily labels 
Schwann cell bodies, and thus most of the calcium changes 
observed occurs in the cell soma (Fig. 7a). Occasionally, how-
ever, some of the bipolar processes are labeled, and in these 
cells, SMRAl-induced intracellular calcium increases in cell 
soma and processes precede morphological changes such as in-
creased lamellapodial activity (Fig. 7 a). For example, arrows on 
the Schwann cell images from 35 and 40 min poststimulation 
panels (Fig. 7a) indicate the lamellapodia or membrane protru-
sions induced by the antibody exposure. Changes in intracellular 
calcium preceded these morphological changes (Fig. 7 a; 5-30 
min). 
Measurement of calcium levels in Schwann cells bathed in 
culture medium devoid of mAbs indicates that calcium levels 
do not change randomly (Fig. 7b). Similarly, exposure to a con-
trol Schwann cell surface molecule antibody, SMRA6, did not 
alter internal calcium levels (Fig. 7 b). 
Changes in Schwann cell protein tyrosine phosphorylation 
induced by SMRA I mAb 
Changes in protein tyrosine phosphorylation were monitored at 
various time intervals after antibody stimulation by immuno-
blotting cell extracts with antibodies to phosphotyrosine. After 
590 Anton et al. • C09's Effect on Peripheral Glia 
a. 
b. 80 
--0--- SMRAI (n:l6) 
T ······-<>-·-·· SMRA6 (n:l4) 
60 ····0···· Opti-MEM (n: IO) 
-~ 
~ 
<l 
~ 
.._, 40 
-~ 
= Oil .... 
t/.l 
+ 
+ 8 
20 
0 
A 
TIME (minutes) 
Figure 7. SMRA I evoked increase in intracellular calcium in Schwann cells. a, Pseudocolor images of Fluo 3-AM loaded Schwann cells were 
obtained prior to and after expasure to SMRA I antibodies as described in Materials and Methods. Minutes after the exposure to antibodies is 
noted in the bottom of each panel. Higher fluorescent intensities, and thus higher calcium levels are coded as white followed by red. Blue indicates 
lower fluorescent intensities (white > red > blue). Arrowheads indicate lamellapodia or membrane protrusions induced by the mAb. b, Changes in 
fluorescence(% M IF) in Schwann cells before and after exposure to SMRAI (n = 16) or SMRA6 (n - 14) antibodies were quantified and plotted 
as a function of time. /\ indicates the time at which antibodies were perfused in. Changes in Schwann cells left unperturbed in opti-MEM medium 
(n = 10) were also illustrated. Only SMRAI induced a rise in intracellular calcium level which eventually retumed to baseline level. No changes 
were observed with either SMRA6 or opti-MEM medium. Scale bar in A, 20 µm. 
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Figure 8. Changes in tyrosine phos-
phorylation ofSchwann cell proteins in 
response to SMRAI mAb exposure. a, 
Primary Schwann cells were incubated 
with SMRA I mAb, SMRAS mAb, or 
left unperturbed in RPMl/10% FCS 
medium for 45 min. Cells were then 
harvested and probed with anti-phos-
photyrosine antibodies as described in 
Materials and Methods. Increased 
phosphorylation of several proteins were 
observed following exposure to SMRA I, 
but not to SMRA5 or RPMl/l 0% FCS. 
Molecular weights of the proteins are 
noted at left in kDa. b, a 125 kDa pro-
tein was transiently phosphorylated 5 
min after exposure to SMRA I. Neither 
SMRA5 nor RPMl/10% FCS affected 
the phosphorylation of this protein. 
Time interval after the exposure to an-
tibodies is noted at the top of each lane. 
125-
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48 hr in culture, primary Schwann cells were incubated with 
SMRAl mAb for 5, 10, 15, 25, 35, and 45 min before collecting 
the cells for analysis. Since primary Schwann cells exposed to 
the antibody begin to display morphologica.l changes by 45 min, 
we hypothesized that analysis at time intervals mentioned above 
should be sufficient to detect impo11ant ty:rosine phosphoryla-
tion events induced by the mAb. Over this period, phosphor-
ylation of proteins of 220, 210, 185, 170, 80, 75, 26, 28, and 8 
kDa increased substantially relative to the amount of phos-
phorylation of those proteins in cells left untreated or treated 
with the control mAb, SMRA5 (Fig. 8a). Protein phosphory-
lation was also observed with B2Cl 1 by Hadjiargyrou and Pat-
terson (personal communications). A 125 kDa protein was tran-
siently phosphorylated 5 min after stimulation with SMRAI; 
phosphorylation of this protein returned to basal levels within 
another 5 min (Fig. Sb). We did not detect any significant changes 
in dephosphorylation of proteins induced by SMRA 1, even with 
the enhanced chemoluminescence (ECL) method. 
Discussion 
During the development and regeneration of peripheral nerves, 
migrating Schwann cells participate in interactions with other 
Schwann cells, with axons, and with extracellular matrix mol-
ecules that play a crucial role in axonal growth, guidance, and 
ensheathrrient. We have shown that mAbs against a cell surface, 
transmembrane 26 kDa glycoprotein, CD9, regulate Schwann 
cell migration on living axons and on basement membrane/ 
extracellular matrix substrates. This regulation appears to in-
volve changes in calcium levels and tyrosine phosphorylation. 
In the preceding article Hadjiargyrou and Patterson (1994) 
demonstrate that immobilized, anti-CD9 mAbs modulate 
Schwann cell mitosis and adhesion. B2Cl l , the mAb that is 
mitotic in their experiments, is also a potent enhancer ofSchwann 
cell migration in our assays. However, B2Cl I produces its effect 
on migration ai a concentration (I 00 ng/ml) well below its min-
imal mitotic dosage. Soluble SMRAI mAb does not block or 
induce Schwann cell mitosis in cell proliferation assays (data 
not shown). Furthermore, ROCA2, a CD9 antibody without 
any demonstrable mitotic effect, also enhances migration in our 
assays. Thus, the enhanced migration we observe in our assays 
with CD9 antibodies is not an indirect result of increased 
Schwann cell mitosis. Nevertheless, CD9 could regulate both 
mitosis and migration ofSchwann cells in vivo, where these two 
different Schwann cell behaviors are temporally separated. If 
the distribution of CD9 is also spatially separated, in terms of 
where it is expressed and the complexes it forms with other 
molecules, then it is not difficult to hypothesize that the temporal 
and spatial regulation ofCD9 may modulate distinctly different 
behaviors (i.e., mitosis, migration, and myelination) in Schwann 
cells. CD9 is present in peripheral nerves during these different 
Schwann cell behaviors (Tole and Patterson, 1993; Kaprielian 
et al., 1994). Precisely how CD9 might be modified to function 
as a modulator of these varied behaviors remains unknown. 
Interestingly, the mitotic effect of CD9 antibodies requires that 
the mAbs be immobilized, whereas the effect of the mAbs on 
migration could be elicited by soluble mAbs, indicating that 
CD9 can modulate different behaviors in the same cell under 
different circumstances. 
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A dynamic regulation of adhesion between Schwann cells, 
axons, and their surrounding matrix is likely to determine the 
migratory behavior of Schwann cells. Regulation of cell-sub-
strate adhesion by CD9 may well be a component in the en-
hanced migration induced by CD9 antibodies. The ability of 
CD9 mAbs to enhance Schwann cell migration on normal, adult 
sciatic nerve substrates that are generally not supportive of cell 
adhesion or growth (Sandrock and Matthew, 1987; Bedi et al., 
1992; Anton and Matthew, unpublished observations), as well 
as the enhanced affinity between neurites and Schwann cells in 
the presence of the SMRA 1 mAb, support this hypothesis. In 
previous studies, mAbs to CD9 have been shown to increase 
homotypic and heterotypic cell-<:ell adhesion of platelets, pre-B 
cells, and endothelial cells (Jennings et al., 1990; Masellis-Smith 
et al., 1990; Forsyth, 1991 ). Moreover, overexpression of CD9 
in various non-neural cell lines suppressed cell motility (lkey-
ama et al., 1993). Taken together, these results strengthen the 
idea that CD9 is an important regulator of motility-related, 
adhesive events in the PNS. 
What are the mechanisms whereby CD9 regulates Schwann 
cell migration? It is likely that the binding of SMRAl to CD9 
on the Schwann cell surface triggers a cascade of intracellular 
events, resulting ultimately in changes in Schwann cell mor-
phology and motility. SMRAl probably acts like the yet to be 
identified natural ligand of CD9. Alternately, SMRAl might 
block an inhibitory function of CD9, thus allowing Schwann 
cells to respond in a positive fashion to its environmental cues. 
Studies done in platelets are instructive in deciphering the cas-
cade of intracellular events that follows the activation ofCD9. 
In platelets, mAb binding to CD9 elicits phosphatidyl inositol 
biphosphate (PIP2) hydrolysis which eventually causes the re-
lease of calcium from internal storage organelles, activation of 
protein kinases, and increased cellular binding to cell adhesion 
molecules such as fibronectin (Seehafer and Shaw, 1991; Kroll 
et al., 1992; Yatomi et al., 1993). Similarly, mAbs to cell ad-
hesion molecules LI and N-CAM are also thought to influence 
a similar set of second messengers in neural cells during regu-
lation of neural cell adhesion (Schuch et al., 1989). In an effort 
to understand the signal transduction steps that connect the 
CD9-SMRA1 mAb binding to the morphological and motility 
changes in Schwann cells, we examined two signal transduction 
events associated often with changes in cell shape and motility: 
protein tyrosine phosphorylation and changes in calcium con-
centration. 
In neurons, intracellular calcium mediates the transduction 
of environmental signals into motility and morphological re-
sponses by selectively influencing different components of the 
neuronal cytoskeleton (Forscher, 1989; Kater and Mills, 1991 ). 
In neural crest cells, changes in internal calcium levels influence 
both the degree of cell-<:ell adhesion and the onset of cell mi-
gration (Newgreen and Gooday, 1985; Doherty et al., 1991). 
We provide evidence that CD9 mAb-induced changes in intra-
cellular calcium influence neural crest-derived Schwann cells in 
an analogous manner. Using a calcium indicator, Fluo-3AM, 
which has been previously used to study intracellular Ca2+ 
changes in Schwann cells (Jahromi et al., 1992), we find that 
SMRAl increases intracellular Ca2+ by 63 ± 9% within 35 min 
of stimulation. This gradual rise in calcium over minutes is 
typical of studies where antibodies are used to modulate intra-
cellular calcium (Schuch et al., 1989; Hato et al., 1990). The 
rise in internal calcium could be the result of activated cell 
surface calcium channels or release of calcium from internal 
stores. In human platelets, both of these pathways are involved 
in the calcium rise induced by anti-CD9 antibodies (Favier et 
al., 1989). How does this internal calcium rise lead to enhanced 
cell motility in Schwann cells? Kater et al. ( 1988) hypothesized 
that there is an optimal level of intracellular calcium for cell 
motility and growth. It is possible that under the control con-
ditions in our assays, Schwann cells migrate slowly, partly as a 
result of suboptimal levels of intracellular calcium. The SMRA l 
mAb stimulation may raise the intracellular calcium concen-
tration closer to the optimal level and thus stimulate cell mi-
gration. 
Although it is evident that the SMRA I mAb induces changes 
in intracellular second messenger systems, the interrelationship 
between these changes remains unclear. Since tyrosine phos-
phorylation changes were observed prior to [Ca2 +Ji changes were 
evident, it is conceivable that the latter is a downstream effect 
of tyrosine kinase activity. Conversely, calcium or some other 
second messenger such as 1,2-diacylglycerol that have been gen-
erated from CD9 activation could also activate various tyrosine 
kinases. What is clear, however, is that tyrosine phosphorylation 
of cellular components is an important element in the regulation 
of cell behavior (Ingraham and Maness, 1990; Ullrich and 
Schlessinger, 1990; Schaller et al., 1993). In our studies, mAb 
SMRAl induces tyrosine phosphorylation of 220, 210, 185, 
170, 80, 75, 26, 28, and 8 kDa proteins. Another protein with 
molecular weight 125 kDa was transiently phosphorylated. 
We have yet to characterize the tyrosine phosphorylated pro-
teins beyond their molecular weights. However, several of these 
phosphorylated molecules could be important regulators of 
Schwann cell migratory behavior. For example, the 125 kDa 
and 70 kDa tyrosine phosphorylated proteins could be focal 
adhesion kinase p125FAK and paxillin, respectively. Both are 
important focal adhesion-associated proteins that are thought 
to play crucial roles in cell adhesion, growth, shape, and motility 
(Burridge et al., 1992; Zachary and Rozengurt, 1992). The 160 
kDa protein could be an a-subunit of an integrin receptor, since 
the adhesive effect of CD9 has been shown to require an as-
sociation with integrin receptors, and tyrosine phosphorylation 
of an integrin subunit could be a necessary step in this process 
(Slupsky et al., 1989). Tyrosine phosphorylation ofintegrins has 
also been proposed as a mechanism for the regulation of inte-
grin-extracellular matrix affinity, a process important for cell 
motility (Hynes, 1992). Furthermore, mAb SMRAl appears to 
induce a transformation in Schwann cells from a quiescent, 
relatively nonmotile state to an actively motile state. In Schwann 
cells, several proteins have been shown to regulate cell differ-
entiation from one behavioral state to another. Examples of 
such proteins include, c-fos, c-src, SCIP, ras, N-myc, pCD25, 
and neu. (Ridley et al., 1988; Hengerer et al., 1990; Monuki et 
al., 1990; Niki tin et al., 1991; Pyykonen and Koistinaho, 1991; 
Sano et al., 1991; Spreyer et al., 1991 ). Of these, neu is of 
particular interest since it is a 185 kDa receptor-like phos-
phoglycoprotein with tyrosine kinase activity that is thought to 
be a transducer molecule for Schwann cell proliferation con-
trolling signals such as GGF (Lonardo et al., 1990; Nikitin et 
al., 1991; Marchionni et al., 1993). Perhaps CD9-induced phos-
phorylation of such a molecule may play an important role in 
a Schwann cell's decision to divide or migrate in response to 
CD9. Thus, it will be of interest to know ifthe 185 kDa protein 
phosphorylated in our assays is neu. 
Studies on molecules that define position in the nervous sys-
tem have identified a putative epitope on CD9 as a molecular 
determinant of position in PNS (Suzuc ct al., 1990; Kaprielian 
and Patterson, 1993). The generation of positional identities in 
the nervous system is likely to involve cell movement and cell 
adhesion. These behaviors are also important elements in ac-
curate and efficient regeneration of mammalian peripheral nerves 
(Brushart, 1990, 1993). The evidence provided here and by 
Hadjiargyrou and Patterson ( 1994) indicate that CD9 is in-
volved in cell movement, adhesion, and mitosis. Such func-
tional effects of CD9 on Schwann cells suggest that CD9 could 
well play a role both in the generation ofrostrocaudal positional 
identity in the developing PNS and in accurate nerve regener-
ation following injury. This idea could be tested in in vivo per-
tubation studies using these CD9 mAbs. In utero surgery could 
be used to expose the early developing PNS to the anti-CD9 
antibodies while the nerve entubulation model could be used 
to study the effects of mAbs on peripheral nerve regeneration 
(Williams et al., 1983; Muneoka et al., 1990). Such in vivo ex-
periments will help in confirming the role of CD9 as an im-
portant functional regulator of Schwann cell behavior in the 
PNS. 
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